Article Details
Retrieved on: 2024-12-23 05:06:03
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Now, Kisunla and Leqembi are rolling out as the amyloid hypothesis still faces doubt. Given the nature of neurological diseases and biopharma's myriad ...
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here